C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/87 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) C07K 1/36 (2006.01) C07K 14/155 (2006.01) C07K 14/79 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2105771
- 39 - Abstract New conjugates in which the bond between a glycoprotein and a nucleic acid-binding substance is provided by means of the carbohydrate component of the glycoprotein, may be used for introducing therapeutically or gene therapeutically active nucleic acids into cells which express upon their surface a protein to which the glycoprotein binds. The glycoprotein is preferably transferrin, the nucleic acid-binding substance is preferably a homologous polycationic polypeptide such as polylysine. The conjugates may be prepared by oxidising the carbohydrate group of the glycoprotein, especially sialic acid, to the aldehyde form and coupling with the nucleic acid-binding substance, which preferably contains amino groups. Complexes containing the conjugates and an effective nucleic acid are a component of pharmaceutical preparations for therapeutic or gene- therapeutic use.
Birnstiel Max L.
Cotten Matthew
Wagner Ernst
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
New conjugates, consisting of a glycoprotein and a nucleic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New conjugates, consisting of a glycoprotein and a nucleic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New conjugates, consisting of a glycoprotein and a nucleic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1742875